IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 471 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  Search
 
  
Resource Links
   Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
   Article in PDF (237 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)

 
In This Article
  Acknowledgement
   References
   Article Tables

 Article Access Statistics
    Viewed2297    
    Printed20    
    Emailed0    
    PDF Downloaded135    
    Comments [Add]    

Recommend this journal

 


 
 Table of Contents    
LETTER TO THE EDITOR
Year : 2013  |  Volume : 45  |  Issue : 5  |  Page : 534-535
 

Prescribing practices in private health facilities in Delhi (India)


1 Department of Pharmacology, Maulana Azad Medical College, University of Delhi, New Delhi, India
2 Department of Pharmacology, Delhi Society for Promotion of Rational Use of Drugs, Delhi, India
3 Department of ENT, Lok Nayak Hospital, New Delhi, India

Date of Web Publication6-Sep-2013

Correspondence Address:
Vandana Roy
Department of Pharmacology, Maulana Azad Medical College, University of Delhi, New Delhi
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0253-7613.117762

Rights and Permissions



How to cite this article:
Roy V, Gupta U, Gupta M, Agarwal AK. Prescribing practices in private health facilities in Delhi (India). Indian J Pharmacol 2013;45:534-5

How to cite this URL:
Roy V, Gupta U, Gupta M, Agarwal AK. Prescribing practices in private health facilities in Delhi (India). Indian J Pharmacol [serial online] 2013 [cited 2019 Jun 25];45:534-5. Available from: http://www.ijp-online.com/text.asp?2013/45/5/534/117762


Sir,

The private health sector provides 80% of all out-patient care in India.[1] The main thrust of the Government's drug policy has been on the manufacturing and marketing of medicines in the private sector and very little to the actual use of medicines, which are left to the market forces. The National Health policy 2002 (Government of India), has emphasized on the need for standard treatment regimens, in both public and private sector. The Government of Delhi also has a policy of use of only essential medicines. This however is applicable only in public health facilities.

The present study was designed with the aim of assessing prescribing pattern and compliance of medicines prescribed and sold in the private health facilities with the essential medicines list (EML). A prospective, randomized, study using the methodology stated in the World Health Organization's (WHO) manual on indicators for monitoring national drug policies was conducted.[2] The study was approved by the Institutional Ethics Committee. The sample frame was the city of Delhi. Its nine administrative districts were combined to give five zones north, south, east, west, and central. A total of 27 pharmacies were selected by multistage sampling. A minimum of 30 prescriptions each were collected from all pharmacies. They were analyzed using WHO's basic drug (medicine) use indicators for health facilities and some indicators for evaluating national drug policies.[2],[3]

The indicators used were (i) average number of drugs per prescription (ii) percentage of prescriptions encounters with at least one injection (iii) percentage of prescriptions encounters with anti-microbials (the list of anti-microbials was defined before) (iv) percentage of drugs prescribed by generic names (v) percentage of drugs prescribed from the EML.

In addition, (vi) percentage of tonics (vitamins, minerals, hematinics, enzymes, nutritional supplements) (vii) percentage of fixed dose drug combinations (FDCs) prescribed and (viii) percentage of complete prescriptions were also analyzed. A complete prescription was defined as one, where the name of the medicine, dose and frequency of administration and duration of therapy were all written by the prescriber. The prescribing of medicines from the EML was assessed by analyzing the sales of medicines in the private pharmacies in two ways.

Country drug sales: The number of medicines being sold from the most recent National (2003) and Delhi State EML (2006), out of the 50 best-selling medicines in the market in India was analyzed for the years 2006, 2007, and 2008. There is a national EML and states may formulate their own EML based on local morbidity patterns and need.

State medicine sales: To assess the use of medicines from the Delhi State EML, the percentage of medicines from the state EML sold, out of the total number of medicines sold was calculated. To calculate this indicator, the first 30 medicines sold in the private pharmacies were recorded. All brand or generic medicines sold with or without a prescription with dosage form were included. If the medicines contained one active ingredient, which is on the EML and other active constituents, which are not on the EML, they were not included. For combination medicines, only the ones from the EML were included.

The number of prescriptions obtained was 823 with a total of 2164 medicines prescribed. Anti-microbials were the largest number of medicines prescribed (19.6%), followed by analgesics, anti-inflammatory, anti-pyretics (15.5%), and tonics (11.55%). The prescribing indicators are shown in [Table 1]. The number of medicines from the EML, among the top 50 selling medicines in the country ranged from 42% to 44% for national and 42% to 48% for Delhi State EML over 3 years. The percentage of medicines sold from the EML ranged from 27.64% to 39.24.2% in different zones in Delhi.
Table 1: Prescribing indicators in private health facilities: Inter-zone comparison

Click here to view


Majority of prescriptions were incompletely written. This could be due to a basic lack of training in prescription writing or unawareness about the importance of writing a complete prescription. Prescribing of generics was very less. Brand names are reminded continuously to doctors by medical representatives of drug companies and other forms of drug advertising, whereas non-proprietary names are only taught in medical colleges. Prescribing generics offers economic advantages to patients. In most countries where use of generic medicines has been promoted it has primarily been through supportive legislation and regulations.[4]

There appears to be excessive use of FDCs, which are not recommended, unless they are of proven efficacy and rationality. Although only a handful of essential FDC have been recognized by WHO, National (India) and Delhi State EML, a wide variety of FDCs are available in the Indian market today, accounting for 40-60% of the total number of formulations (nearly 100,000) in India.[5] Inter zone comparison of prescribing indicators revealed significant differences. These differences highlight the lack of uniformity or standards in prescription writing.

The impact of the Governments EML, both National and State on medicine prescribing and sales in the city was very less. Only one-third of the medicines were prescribed and approximately the same number were among the top 50 selling medicines in the country and in the first 30 medicines sold in the private pharmacies. The WHO has encouraged countries to adopt a list of essential medicines. Use of essential medicines offers many advantages such as increasing availability of medicines and decreasing costs. It is also easier to be better informed about a restricted list of medicines. Hence, greater use of the EML would aid in rational use of medicines.

The study has highlighted lacunae in skills in prescription writing with less use of medicines from the EML and increased use of proprietary medicines in private health facilities in Delhi. Regulatory and educational interventions to sensitize doctors on issues related to essential medicine concept and rational prescribing are urgently required.


  Acknowledgement Top


We gratefully acknowledge the support given by the World Health Organization, Regional South East Asia office , through the Delhi Society for Promotion of Rational use of Drugs for the conduct of the study.We thank Ms Kalaivani, Scientist, Department of Bio statistics, All India Institute of Medical Sciences, New Delhi, for providing assistance in statistical evaluation

 
  References Top

1.Rao KS, Nundy M, Dua AS. Delivery of health services in the private sector. In: Lal PG, Byword Editorial Consultants, editors. Financing & delivery of health services in India. National Commission on Macroeconomics & Health. Ministry of Health & Family Welfare. Government of India, New Delhi. 2005. p. 89-104.  Back to cited text no. 1
    
2.Jakobowicz PB, Rainhorn JD, Reich MR, editors. Indicators for Monitoring National Drug Policies: A Practice Manual. Geneva: World Health Organization; 1994. WHO/DAP/94.12.  Back to cited text no. 2
    
3.World Health Organization. How to Investigate Drug Use in Health Facilities: Selected Drug Use Indicators. Geneva: World Health Organization; 1995. WHO/DAP/93.1.  Back to cited text no. 3
    
4.World Health Organization. Public-Private Roles in the Pharmaceutical Sector. Implications for Equitable Access and Rational Drug Use. Health Economics and Drugs. Action Programme on Essential Drugs. Geneva: World Health Organization; 1997. WHO/DAP/97.2.  Back to cited text no. 4
    
5.Srinivasan S, Phadke A. Pharma policy 2012 and it's discontents. Econ Polit Wkly 2013;XLVIII:38-42.  Back to cited text no. 5
    



 
 
    Tables

  [Table 1]



 

Top
Print this article  Email this article
 

    

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow